TRANSLATIONAL RESEARCH-03 MULTIPLE MECHANISMS MODULATE TEMOZOLOMIDE RESISTANCE AND ARE POTENTIAL TARGETS FOR GLIOBLASTOMA THERAPY.

por Kitange, Gaspar, Sarkaria, Jann
Publicado 2023

Characterization of relative biological effectiveness for conventional radiation therapy: a comparison of clinical 6 MV X-rays and (137)Cs

por Howard, Michelle, Beltran, Chris, Sarkaria, Jann, Herman, Michael G
Publicado 2017

Perivascular Stromal Cells Instruct Glioblastoma Invasion, Proliferation, and Therapeutic Response within an Engineered Brain Perivascular Niche Model

por Ngo, Mai T., Sarkaria, Jann N., Harley, Brendan A.C.
Publicado 2022

HGG-10. Efficacy of convection-enhanced delivery of GB-13 (IL13.E13K-PE4E) in an orthotopic xenograft model of high-grade glioma is predicated on IL-13Rα2 expression.

por Rechberger, Julian, Porath, Kendra, Schrecengost, Randy, Sarkaria, Jann, Daniels, David
Publicado 2022

Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs

por Zhang, Liang, Zhang, Zhongwei, Mason, Ralph P., Sarkaria, Jann N., Zhao, Dawen
Publicado 2015

Editorial: Targeted Therapies for Glioblastoma: A Critical Appraisal

por Gupta, Shiv K., Kizilbash, Sani H., Daniels, David J., Sarkaria, Jann N.
Publicado 2019

Peptide Carrier-Mediated Non-Covalent Delivery of Unmodified Cisplatin, Methotrexate and Other Agents via Intravenous Route to the Brain

por Sarkar, Gobinda, Curran, Geoffry L., Sarkaria, Jann N., Lowe, Val J., Jenkins, Robert B.
Publicado 2014

MARQUIS: A Multiplex Method for Absolute Quantification of Peptides and Post-Translational Modifications

por Curran, Timothy G, Zhang, Yi, Ma, Daniel J., Sarkaria, Jann N., White, Forest M
Publicado 2015

The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma

por Javier, Rodrigo, Wang, Wenxia, Drumm, Michael, McCortney, Kathleen, Sarkaria, Jann N., Horbinski, Craig
Publicado 2022

LOCL-07 LOCO-REGIONAL INFUSION OF GB-13 (IL13.E13K-PE4E) AS A POTENTIALLY PROMISING TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA

por Rechberger, Julian, Khatua, Soumen, Campian, Jian, Sarkaria, Jann, Schwartz, Jonathan, Daniels, David, Schrecengost, Randy
Publicado 2022

Main Manuscript for Cell migration simulator-based biomarkers for glioblastoma

por Hou, Jay, McMahon, Mariah, Sarkaria, Jann N., Chen, Clark C., Odde, David J.
Publicado 2023

MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical Investigation

por Pellot Ortiz, Karolina I., Rechberger, Julian S., Nonnenbroich, Leo F., Daniels, David J., Sarkaria, Jann N.
Publicado 2023

Quantifying Glioblastoma Drug Response Dynamics Incorporating Treatment Sensitivity and Blood Brain Barrier Penetrance From Experimental Data

por Massey, Susan Christine, Urcuyo, Javier C., Marin, Bianca Maria, Sarkaria, Jann N., Swanson, Kristin R.
Publicado 2020

DIPG-15. CONCURRENT GB-13 (IL13.E13K-PE4E) IMPROVES THE EFFICACY OF RADIATION THERAPY IN DIFFUSE INTRINSIC PONTINE GLIOMA

por Rechberger, Julian S, Schrecengost, Randy S, Zhang, Liang, Ge, Jizhi, Nonnenbroich, Leo F, Sarkaria, Jann N, Daniels, David J
Publicado 2023

Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors

por Griffith, Jessica I., Rathi, Sneha, Zhang, Wenqiu, Zhang, Wenjuan, Drewes, Lester R., Sarkaria, Jann N., Elmquist, William F.
Publicado 2020

IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma

por Rechberger, Julian S., Porath, Kendra A., Zhang, Liang, Nesvick, Cody L., Schrecengost, Randy S., Sarkaria, Jann N., Daniels, David J.
Publicado 2022

Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype

por Lewis-Tuffin, Laura J., Rodriguez, Fausto, Giannini, Caterina, Scheithauer, Bernd, Necela, Brian M., Sarkaria, Jann N., Anastasiadis, Panos Z.
Publicado 2010

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

por Allen, Cory, Opyrchal, Mateusz, Aderca, Ileana, Schroeder, Mark A., Sarkaria, Jann N., Domingo, Evidio, Federspiel, Mark J., Galanis, Evanthia
Publicado 2012

Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme

por Tivnan, Amanda, Zakaria, Zaitun, O'Leary, Caitrín, Kögel, Donat, Pokorny, Jenny L., Sarkaria, Jann N., Prehn, Jochen H. M.
Publicado 2015

H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers

por Fang, Dong, Gan, Haiyun, Cheng, Liang, Lee, Jeong-Heon, Zhou, Hui, Sarkaria, Jann N, Daniels, David J, Zhang, Zhiguo
Publicado 2018